Actiq vs. Depakote: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Actiq and Depakote. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 179,289 people who take Actiq and Depakote, and is updated regularly.
What is Actiq?
Actiq has active ingredients of fentanyl citrate. It is often used in pain. eHealthMe is studying from 27,583 Actiq users. Check the latest studies of Actiq.
What is Depakote?
Depakote has active ingredients of divalproex sodium. It is often used in bipolar disorder. eHealthMe is studying from 55,581 Depakote users. Check the latest studies of Depakote.
179,289 people who take Actiq and Depakote are studied.

Drugs being compared in this study:
- Actiq (fentanyl citrate)
- Depakote (divalproex sodium)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Actiq:
- not at all: 2.01 %
- somewhat: 18.73 %
- moderate: 35.45 %
- high: 31.77 %
- very high: 12.04 %
Depakote:
- not at all: 5.08 %
- somewhat: 20.54 %
- moderate: 31.23 %
- high: 29.7 %
- very high: 13.45 %
Want to compare Actiq with Depakote?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Actiq:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Depakote:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on fentanyl citrate and divalproex sodium (the active ingredients of Actiq and Depakote, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Imitrex cause Insomnia? - 8 seconds ago
- Could Saxenda cause Fatigue? - 14 seconds ago
- Could Armodafinil cause Dysstasia? - 16 seconds ago
- Drug interactions of Sodium Chloride and Ester C - 24 seconds ago
- Could Alprazolam cause Dry Eye Syndrome? - 25 seconds ago
- Could Digoxin cause Injection Site Reaction? - 26 seconds ago
- Could Incruse Ellipta cause Sputum Discolored? - 29 seconds ago
- Drug interactions of Loraz and Magnesium Citrate - 29 seconds ago
- Ankylosing Spondylitis and Urine Abnormality - 34 seconds ago
- Pristiq vs. Tofranil-Pm, side effect and effectiveness comparison - 34 seconds ago